Inhibitory effect and related mechanism of decitabine combined with gemcitabine on proliferation of NK/T cell lymphoma cells

Inhibitory effect and related mechanism of decitabine combined with gemcitabine on proliferation of NK/T cell lymphoma cells

Background: EBV-associated lymphoma is a neoplasm with a poor prognosis, highly aggressive, and progressive rapidly. There is no standard clinical treatment protocol. Decitabine and gemcitabine are known to have anticancer properties against cells of various cancer, respectively. However, the effect...

Full description

Bibliographic Details
Main Authors: Lanke Lin, Xiangqin Liu, Hui Yu, Huan Deng, Kun Peng, Jiang Chen, Chunle Zhang, Tao Jiang, Xiaoqi Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Pharmacology
Subjects:
NK/T cell lymphoma
decitabine
gemcitabine
ferroptosis
apoptosis
drug combination
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1134895/full

Similar Items

Similar Items